Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia, Moderate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT06632470
What this trial is testing

Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Moderate Neurocognitive Impairment (Dementia)

Who this might be right for
DementiaModerate Dementia
Baermed 54
Large-scale testing (Phase 3)UnknownNCT00314912
What this trial is testing

Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bellus Health Inc. - a GSK company 650
Testing effectiveness (Phase 2)Study completedNCT02079909
What this trial is testing

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)

Who this might be right for
Alzheimer's Disease
FUJIFILM Toyama Chemical Co., Ltd. 482
Post-approval studies (Phase 4)Study completedNCT00549601
What this trial is testing

Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 142
Testing effectiveness (Phase 2)Study completedNCT00285025
What this trial is testing

Study of the Effect of SR57667B in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Sanofi 500
Early research (Phase 1)Study completedNCT00087789
What this trial is testing

CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sangamo Therapeutics 10
Not applicableActive Not RecruitingNCT06160908
What this trial is testing

Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease (NIR4AD)

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 38
Testing effectiveness (Phase 2)Study completedNCT05269173
What this trial is testing

Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Capital Medical University 240
Not applicableStudy completedNCT05295966
What this trial is testing

Multisensory Physical Exercises in People With Cognitive Impairment

Who this might be right for
Dementia
Universidad Rey Juan Carlos 25
Not applicableUnknownNCT05488951
What this trial is testing

The Influence of the Otago Exercise Program on Executive Function Among People Living With Mild to Moderate Dementia

Who this might be right for
Dementia
Augusta University 42
Testing effectiveness (Phase 2)Ended earlyNCT01690195
What this trial is testing

Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 343
Testing effectiveness (Phase 2)Ended earlyNCT00299988
What this trial is testing

Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Weill Medical College of Cornell University 24
Not applicableWithdrawnNCT03352024
What this trial is testing

Impact of Hypno-analgesia on Pain During a Lumbar Puncture for Diagnosis of Alzheimer's Disease

Who this might be right for
Cognitive ImpairmentAlzheimer Disease
University Hospital, Montpellier
Not applicableStudy completedNCT06812442
What this trial is testing

Effectiveness of a 3-month Individual Reminiscence Therapy Program in Older Adults With Alzheimer's Disease

Who this might be right for
DementiaAlzheimer DiseaseCognitive Impairment
Rsocialform - Geriatria, Lda 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07832383
What this trial is testing

Evaluation of NBI-1117567 in Participants With Mild to Moderate Alzheimer's Disease (AD) Taking a Background Acetylcholinesterase Inhibitor

Who this might be right for
Alzheimer's Disease
Neurocrine Biosciences 135
Testing effectiveness (Phase 2)UnknownNCT01120002
What this trial is testing

Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Osaka City University 50
Testing effectiveness (Phase 2)Study completedNCT04491006
What this trial is testing

ATH-1017 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia of Alzheimer Type
LeonaBio 77
Early research (Phase 1)Study completedNCT03008161
What this trial is testing

Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Proclara Biosciences, Inc. 83
Not applicableStudy completedNCT06583161
What this trial is testing

Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15)

Who this might be right for
Myocardial InfarctionIschemic StrokeAngina Pectoris+12 more
Harvard School of Public Health (HSPH) 503,325
Not applicableStudy completedNCT04008342
What this trial is testing

Multisensory Stimulation in Dementia.

Who this might be right for
Dementia
Federal University of Minas Gerais 60
Next Page